Agile Therapeutics Has Priced Its Public Offering Of 1.89M, Together With Accompanying Common Stock Warrants, At $3.9551 Per Share (Or Pre-funded Warrant) And Accompanying Warrants, For A Gross Proceed Of Approximately $7.5M
Agile Therapeutics Has Priced Its Public Offering Of 1.89M, Together With Accompanying Common Stock Warrants, At $3.9551 Per Share (Or Pre-funded Warrant) And Accompanying Warrants, For A Gross Proceed Of Approximately $7.5M
Agile Therapeutics已將其189萬美元的公開發行以及隨附的普通股認股權證定價爲每股3.9551美元（或預先出資的認股權證）和隨附的認股權證，總收益約爲750萬美元
Agile Therapeutics Has Priced Its Public Offering Of 1.89M, Together With Accompanying Common Stock Warrants, At $3.9551 Per Share (Or Pre-funded Warrant) And Accompanying Warrants, For A Gross Proceed Of Approximately $7.5M
Agile Therapeutics已將其189萬美元的公開發行以及隨附的普通股認股權證定價爲每股3.9551美元（或預先出資的認股權證）和隨附的認股權證，總收益約爲750萬美元
資訊熱榜
更新時間